> Fitness News
Asthma Allergy News
Diabetes News
Women's Health News
Men's Health News

Personal Archive
My Account

About Us
Advertise With Us
Feed Your Site
Contact Us

Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

Performance-Enhancing Drug Use Widespread in U.S.
Use of PEDs more widespread than thought; can have adverse health consequences

FRIDAY, Dec. 27, 2013 (HealthDay News) -- Use of performance-enhancing drugs (PEDs) is more widespread than previously thought and can have adverse health consequences, according to a scientific statement published online Jan. 1 in Endocrine Reviews.

Noting that most PED users are not athletes, but non-athlete weightlifters, Harrison G. Pope Jr., M.D., from Harvard Medical School in Belmont, Mass., and colleagues reviewed the literature relating to PED use.

The researchers note that use of androgenic-anabolic steroids (AAS) is widespread in Western countries and highest in the United States, with one million men estimated to have experienced AAS dependence at some point. The most commonly used PEDs are AAS, as well as human growth hormone, insulin, and erythropoietins; users often combine multiple drugs. PED users often engage in other high-risk health behaviors as well as concomitant drug use, and may be susceptible to antisocial or violent behaviors. PED use has been associated with an increased risk of death and adverse effects on several organ systems, including cardiovascular effects, hematological effects, psychiatric and neurological effects, and hormonal and metabolic effects. Further research is needed on the long-term adverse consequences of PED use, based on long-term observational studies; prevalence and patterns in use; understanding the mechanistic pathways involved in adverse effects; AAS withdrawal; and innovative approaches to raising public awareness of the serious health consequences associated with PED use.

"The use of performance-enhancing drugs is far more prevalent than is generally believed and deserves substantially greater investigation of its medical consequences, mechanisms, prevention and treatment," Pope said in a statement.

Several authors disclosed financial ties to the pharmaceutical and biotechnology industries. Several authors disclosed testifying in cases related to anabolic-androgenic steroid use.

Full Text

Copyright © 2013 HealthDay. All rights reserved.

Back to Top Stories